Instrument Inactif

Autres langues EKIMAS Corporation Other OTC

Actions

ASNB

US28265K1060

Autres langues

14/07	Tranche Update on Nordicus Partners Corporation's Equity Buyback Plan announced on November 14, 2025.
14/07	Nordicus Partners Corporation Reports Earnings Results for the Full Year Ended March 31, 2026
14/07	Nordicus Partners Corporation Auditor Raises 'Going Concern' Doubt
13/07	Nordicus Partners Corporation Announces Resignation of Andrew J. Ritter from Director and Board Committee Roles, Effective July 7, 2026
15/06	Nordicus Partners Corporation Corporate Update
30/04	Nordicus Partners Corporation announced that it has received $0.554125 million in funding
31/03	Nordicus Partners Corporation announced that it expects to receive $0.554125 million in funding
13/02	Tranche Update on Nordicus Partners Corporation's Equity Buyback Plan announced on November 14, 2025.
13/02	Nordicus Partners Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
06/02	Nordicus Partners Corporation Corporate Update
04/02	Nordicus Partners Corporation Announces Establishment of Board Committees
05/12	Nordicus Partners Corporation announced that it has received $1.144 million in funding
14/11	Nordicus Partners Corporation announces an Equity Buyback for 200,000 shares.
14/11	Tranche Update on Nordicus Partners Corporation's Equity Buyback Plan announced on November 14, 2025.
14/11	Nordicus Partners Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
13/11	NoviThera has initiated the first efficacy animal studies
22/10/25	Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats.
20/10/25	Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
20/10/25	Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
03/10/25	Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS
03/10/25	Nordicus Partners Corporation Announces the Formation of a New Company, NoviThera ApS
18/09/25	Nordicus Partners Corporation announced that it has received $2.00925 million in funding
02/09/25	Nordicus Partners applies to uplist common stock to Nasdaq
02/09/25	Nordicus Partners Corporation Applies to Uplist to the Nasdaq Capital Market
20/08/25	Nordicus Partners Corporation Reports Earnings Results for the First Quarter Ended June 30, 2025